SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,778,000 | -42.1% | 108,000 | -41.1% | 0.31% | -42.1% |
| Q3 2017 | $9,984,000 | +38.7% | 183,500 | +31.9% | 0.54% | +20.5% |
| Q2 2017 | $7,197,000 | +119.4% | 139,100 | +166.5% | 0.44% | +114.5% |
| Q1 2017 | $3,281,000 | +19.1% | 52,200 | 0.0% | 0.21% | -8.4% |
| Q4 2016 | $2,754,000 | -50.4% | 52,200 | -49.3% | 0.23% | -49.8% |
| Q3 2016 | $5,557,000 | +33.6% | 102,900 | 0.0% | 0.45% | +15.7% |
| Q2 2016 | $4,158,000 | +269.3% | 102,900 | +220.6% | 0.39% | +241.2% |
| Q1 2016 | $1,126,000 | +98.9% | 32,100 | +126.1% | 0.11% | +16.3% |
| Q4 2013 | $566,000 | – | 14,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |